|
|
|
This is the preliminary program for the 2009 Joint Statistical
Meetings in Washington, DC.
|
|
|
The views expressed here are those of the individual authors and not necessarily those of the ASA or its board, officers, or staff. Back to main JSM 2009 Program page |
= Applied Session,
= Theme Session,
= Presenter
505
|
Wed, 8/5/09, 2:00 PM - 3:50 PM | CC-101 |
| Statistical and Regulatory Challenges in Alzheimer's Disease Clinical Trials - Topic Contributed - Papers | ||
|
Biopharmaceutical Section |
||
| Organizer(s): Yonggang Zhao, Wyeth Research | ||
| Chair(s): Yonggang Zhao, Wyeth Research | ||
| 2:05 PM |
Some Statistical and Regulatory Considerations on Alzheimer Trials —  Kun Jin, FDA
|
|
| 2:25 PM |
Statistical Inference and Sample Size Issues for Co-Primary Endpoints in Alzheimer's Disease Trials — Mohammad F. Huque, FDA
|
|
| 2:45 PM |
A Meta-Analytic Model for Alzheimer's Disease Incorporating Both Summary-Level and Patient-Level Data — James A. Rogers, Metrum; Bill Gillespie, Metrum; Kaori Ito, Pfizer Inc.; Marc Gastonguay, Metrum
|
|
| 3:05 PM |
Providing Evidence of Disease Modification — Suzanne Hendrix, Pentara Corporation
|
|
| 3:25 PM | Floor Discussion | |
|
JSM 2009
For information, contact jsm@amstat.org
or phone (888) 231-3473. If you have questions about the Continuing Education program,
please contact the Education Department. |